Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Motonari Yunoki is active.

Publication


Featured researches published by Motonari Yunoki.


European Journal of Pharmacology | 2000

Involvement of K+ channel in procainamide-induced relaxation of bovine tracheal smooth muscle

Tsutomu Nakahara; Hiroshi Moriuchi; Motonari Yunoki; Yuko Kubota; Yoshio Tanaka; Kenji Sakamato; Koki Shigenobu; Kunio Ishii

The relaxant effect of procainamide, a class Ia antiarrhythmic agent, was examined in bovine tracheal smooth muscle. Procainamide produced concentration-dependent decreases in tension and full relaxation in the preparations contracted with methacholine (0.3 microM). By comparison, in preparations contracted with 40 mM K(+), procainamide had only slight relaxant effects. The relaxant effects of cromakalim and salbutamol on 40 mM K(+)-contracted preparations were significantly (P<0.01) smaller than those on 0.3 microM methacholine-contracted ones. On the other hand, the concentration-response relationships for quinidine, lidocaine, mexiletine and propafenone were not so dramatically different between 0.3 microM methacholine- and 40 mM K(+)-contracted preparations. Tetraethylammonium (300 microM), iberiotoxin (30 nM) and Ba(2+) (1 mM) significantly (P<0.05) attenuated the relaxant effects of procainamide on methacholine-induced contractions, whereas apamin (100 nM), 4-aminopyridine (300 microM), and glibenclamide (10 microM) did not affect them. The inhibitory effect of a combination of iberiotoxin and Ba(2+) was greater than that of iberiotoxin or Ba(2+) alone (P<0.01). These results suggest that the activation of at least two types of K(+) (maxi-K(+) and inward rectifier K(+)) channels contributes to the procainamide-induced relaxation of bovine tracheal smooth muscle.


European Journal of Pharmacology | 2003

Lidocaine attenuates muscarinic receptor-mediated inhibition of adenylyl cyclase in airway smooth muscle

Motonari Yunoki; Tsutomu Nakahara; Akiko Mitani; Takeshi Maruko; Yuko Kubota; Kenji Sakamoto; Kunio Ishii

We examined how lidocaine affects muscarinic receptor-mediated inhibition of adenylyl cyclase in bovine tracheal smooth muscles. Lidocaine (100 microM) augmented the relaxant responses to forskolin in the bovine tracheal smooth muscle contracted with methacholine (0.3 microM). On the other hand, lidocaine failed to affect the relaxant effects of forskolin on the histamine (100 microM)- and KCl (40 mM)-contracted preparations. Lidocaine (100 microM) enhanced both basal and forskolin-stimulated cAMP accumulation in the presence of methacholine (0.3 microM). However, in the absence of methacholine, neither basal nor forskolin-stimulated cAMP accumulation was affected by lidocaine. Similar phenomenon was observed when the bovine tracheal smooth muscles were treated with methoctramine (0.03 microM). In radioligand binding experiments, lidocaine inhibited [3H]N-methyl scopolamine binding to cloned human muscarinic receptors (M(1)-M(5)) expressed in Chinese hamster ovary cells. These results suggest that lidocaine prevents muscarinic receptor-mediated signaling pathway and thereby reverses inhibition of adenylyl cyclase by methacholine in bovine tracheal smooth muscle.


European Journal of Pharmacology | 2001

Role of K+ channels in N-acetylprocainamide-induced relaxation of bovine tracheal smooth muscle

Tsutomu Nakahara; Hiroshi Moriuchi; Yoshio Tanaka; Motonari Yunoki; Yuko Kubota; Kenji Sakamato; Koki Shigenobu; Kunio Ishii

We examined the relaxant effects of N-acetylprocainamide, the major hepatic metabolite of procainamide, on bovine tracheal smooth muscle, focusing on the possible involvement of K+ channels. N-acetylprocainamide produced a concentration-dependent and full inhibition of the tension development elicited by methacholine (0.3 or 1 microM). The potency of N-acetylprocainamide in diminishing methacholine-elicited tension development was one-half of that of procainamide. By comparison, N-acetylprocainamide inhibited high-K+ (40 mM)-induced contraction more potently than procainamide though both inhibitions were largely reduced when compared to those against methacholine-induced contraction. Iberiotoxin (30 nM), Ba(2+) (1 mM) or a combination of both agents significantly attenuated the relaxant effect of N-acetylprocainamide on methacholine-induced contraction, whereas apamin (100 nM), 4-aminopyridine (300 microM), and glibenclamide (10 microM) did not affect it. These results suggest that N-acetylprocainamide, similar to procainamide, elicits tracheal smooth muscle relaxation mainly through the activation of plasma membrane K+ channels.


Pharmacology | 2012

The Relaxant Action of Nicorandil in Bovine Tracheal Smooth Muscle

Motonari Yunoki; Tsutomu Nakahara; Hiroshi Moriuchi; Kenji Sakamoto; Kunio Ishii

The relaxant mechanisms of nicorandil were examined by comparing its effects with those of sodium nitroprusside and cromakalim in bovine tracheal smooth muscle. In preparations contracted with methacholine (0.3 µmol/l) or high K+ (40 mmol/l), nicorandil and sodium nitroprusside caused concentration-dependent relaxations. Their relaxant effects on high K+-contracted preparations were smaller than those on methacholine-contracted muscle. Cromakalim relaxed methacholine-contracted preparations, whereas it had no effect on high K+-contracted muscle. The inhibitor of soluble guanylyl cyclase 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ; 5 µmol/l) completely prevented the relaxation induced by lower concentrations (<30 µmol/l) of nicorandil, whereas it partially attenuated relaxation caused by higher concentrations. The ATP-sensitive K+ (KATP) channel blocker glibenclamide only partially attenuated the relaxant responses to nicorandil (at 100 and 300 µmol/l). Combination treatment with ODQ and glibenclamide almost completely prevented nicorandil-induced relaxations. The large-conductance Ca2+-activated K+ channel (Maxi K+ channel) inhibitor iberiotoxin significantly prevented the relaxations induced by lower concentrations (3 and 10 µmol/l) of nicorandil. The preventive effect of iberiotoxin was markedly enhanced under the blockade of KATP channels with glibenclamide. These results suggest that nicorandil relaxes bovine tracheal smooth muscle through 2 mechanisms: opening of KATP channels and activation of the nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) pathway. Nicorandil may also activate Maxi K+ channels, possibly through the NO-cGMP pathway, and the interaction of KATP channels and Maxi K+ channels may affect the relaxant effect of nicorandil in bovine tracheal smooth muscle.


Naunyn-schmiedebergs Archives of Pharmacology | 2002

Inhibitory mechanism of BRL37344 on muscarinic receptor-mediated contractions of the rat urinary bladder smooth muscle.

Yuko Kubota; Tsutomu Nakahara; Motonari Yunoki; Akiko Mitani; Takeshi Maruko; Kenji Sakamoto; Kunio Ishii


Naunyn-schmiedebergs Archives of Pharmacology | 2000

Lidocaine potentiates the relaxant effects of cAMP-elevating agents in bovine tracheal smooth muscle.

Tsutomu Nakahara; Motonari Yunoki; Hiroshi Moriuchi; Kenji Sakamato; Kunio Ishii


Naunyn-schmiedebergs Archives of Pharmacology | 2002

Relaxation and potentiation of cGMP-mediated response by ibudilast in bovine tracheal smooth muscle.

Tsutomu Nakahara; Motonari Yunoki; Hiroshi Moriuchi; Akiko Mitani; Kenji Sakamoto; Kunio Ishii


Naunyn-schmiedebergs Archives of Pharmacology | 2003

Role of the M2 muscarinic receptor pathway in lidocaine-induced potentiation of the relaxant response to atrial natriuretic peptide in bovine tracheal smooth muscle

Motonari Yunoki; Tsutomu Nakahara; Akiko Mitani; Kenji Sakamoto; Kunio Ishii


Naunyn-schmiedebergs Archives of Pharmacology | 2002

Stimulation of muscarinic M2 receptors inhibits atrial natriuretic peptide-mediated relaxation in bovine tracheal smooth muscle.

Tsutomu Nakahara; Motonari Yunoki; Akiko Mitani; Kenji Sakamoto; Kunio Ishii


Naunyn-schmiedebergs Archives of Pharmacology | 2001

Mexiletine inhibits pharmacological actions of salbutamol through blockade of β2-adrenoceptors in bovine tracheal smooth muscle

Tsutomu Nakahara; Yuko Kubota; Kenji Sakamato; Hiroshi Moriuchi; Motonari Yunoki; Kunio Ishii

Collaboration


Dive into the Motonari Yunoki's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge